BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 33933945)

  • 1. UV spectroscopic method for estimation of temozolomide: Application in stability studies in simulated plasma pH, degradation rate kinetics, formulation design, and selection of dissolution media.
    Waghule T; Narayan Saha R; Singhvi G
    Spectrochim Acta A Mol Biomol Spectrosc; 2021 Sep; 258():119848. PubMed ID: 33933945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis and stability study of temozolomide using capillary electrophoresis.
    Andrasi M; Bustos R; Gaspar A; Gomez FA; Klekner A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jul; 878(21):1801-8. PubMed ID: 20627825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absorption, metabolism, and excretion of 14C-temozolomide following oral administration to patients with advanced cancer.
    Baker SD; Wirth M; Statkevich P; Reidenberg P; Alton K; Sartorius SE; Dugan M; Cutler D; Batra V; Grochow LB; Donehower RC; Rowinsky EK
    Clin Cancer Res; 1999 Feb; 5(2):309-17. PubMed ID: 10037179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal engineering of stable temozolomide cocrystals.
    Babu NJ; Sanphui P; Nangia A
    Chem Asian J; 2012 Oct; 7(10):2274-85. PubMed ID: 22615256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-performance liquid chromatographic determination and stability of 5-(3-methyltriazen-1-yl)-imidazo-4-carboximide, the biologically active product of the antitumor agent temozolomide, in human plasma.
    Kim HK; Lin CC; Parker D; Veals J; Lim J; Likhari P; Statkevich P; Marco A; Nomeir AA
    J Chromatogr B Biomed Sci Appl; 1997 Dec; 703(1-2):225-33. PubMed ID: 9448080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemometrics-assisted development of a validated LC method for simultaneous estimation of temozolomide and γ-linolenic acid: Greenness assessment and application to lipidic nanoparticles.
    Beg S; Panda SS; Singh KK
    J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Jun; 1200():123261. PubMed ID: 35533423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced Copper-Temozolomide Interactions by Protein for Chemotherapy against Glioblastoma Multiforme.
    Li X; Shao F; Sun J; Du K; Sun Y; Feng F
    ACS Appl Mater Interfaces; 2019 Nov; 11(45):41935-41945. PubMed ID: 31644262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetics of temozolomide and metabolites in infants and children with primary central nervous system tumors.
    Panetta JC; Kirstein MN; Gajjar A; Nair G; Fouladi M; Heideman RL; Wilkinson M; Stewart CF
    Cancer Chemother Pharmacol; 2003 Dec; 52(6):435-41. PubMed ID: 13680158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of 3-methyl-(triazen-1-yl)imidazole-4-carboximide following administration of temozolomide to patients with advanced cancer.
    Reid JM; Stevens DC; Rubin J; Ames MM
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2393-8. PubMed ID: 9815639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of simple step protein precipitation UHPLC-MS/MS methods for quantitation of temozolomide in cancer patient plasma samples.
    El Mubarak MA; Stylos EK; Chatziathanasiadou MV; Danika C; Alexiou GA; Tsekeris P; Renziehausen A; Crook T; Syed N; Sivolapenko GB; Tzakos AG
    J Pharm Biomed Anal; 2019 Jan; 162():164-170. PubMed ID: 30243056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liposomal temozolomide drug delivery using convection enhanced delivery.
    Nordling-David MM; Yaffe R; Guez D; Meirow H; Last D; Grad E; Salomon S; Sharabi S; Levi-Kalisman Y; Golomb G; Mardor Y
    J Control Release; 2017 Sep; 261():138-146. PubMed ID: 28666727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of gastric pH on the relative oral bioavailability and pharmacokinetics of temozolomide.
    Beale P; Judson I; Moore S; Statkevich P; Marco A; Cutler DL; Reidenberg P; Brada M
    Cancer Chemother Pharmacol; 1999; 44(5):389-94. PubMed ID: 10501912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Voltammetric/UV-Vis study of temozolomide inclusion complexes with cyclodextrin derivatives.
    Krzak A; Bilewicz R
    Bioelectrochemistry; 2020 Dec; 136():107587. PubMed ID: 32645568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biophysical interaction of temozolomide and its active metabolite with biomembrane models: The relevance of drug-membrane interaction for Glioblastoma Multiforme therapy.
    Ramalho MJ; Andrade S; Coelho MÁN; Loureiro JA; Pereira MC
    Eur J Pharm Biopharm; 2019 Mar; 136():156-163. PubMed ID: 30682492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An LC/MS/MS method for the quantitation of MTIC (5-(3-N-methyltriazen-1-yl)-imidazole-4-carboxamide), a bioconversion product of temozolomide, in rat and dog plasma.
    Chowdhury SK; Laudicina D; Blumenkrantz N; Wirth M; Alton KB
    J Pharm Biomed Anal; 1999 Apr; 19(5):659-68. PubMed ID: 10698531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The safety of temozolomide in the treatment of malignancies.
    Trinh VA; Patel SP; Hwu WJ
    Expert Opin Drug Saf; 2009 Jul; 8(4):493-9. PubMed ID: 19435405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-performance liquid chromatographic analysis and stability of anti-tumor agent temozolomide in human plasma.
    Kim H; Likhari P; Parker D; Statkevich P; Marco A; Lin CC; Nomeir AA
    J Pharm Biomed Anal; 2001 Jan; 24(3):461-8. PubMed ID: 11199225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-salting out assisted liquid-liquid extraction (SALLE) HPLC method for estimation of temozolomide from biological samples.
    Jain D; Athawale R; Bajaj A; Shrikhande S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Nov; 970():86-94. PubMed ID: 25240926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of stability of temozolomide in solutions after opening the capsule].
    Kodawara T; Mizuno T; Taue H; Hashida T; Yano I; Katsura T; Inui K
    Yakugaku Zasshi; 2009 Mar; 129(3):353-7. PubMed ID: 19252393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Encapsulation of Temozolomide in a Calixarene Nanocapsule Improves Its Stability and Enhances Its Therapeutic Efficacy against Glioblastoma.
    Renziehausen A; Tsiailanis AD; Perryman R; Stylos EK; Chatzigiannis C; O'Neill K; Crook T; Tzakos AG; Syed N
    Mol Cancer Ther; 2019 Sep; 18(9):1497-1505. PubMed ID: 31213505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.